A Gliadel, BCNU, NSC-409962, Becenun, Carmustine written confirmation (Gliadel, BCNU, NSC-409962, Becenun, Carmustine WC) is an official document issued by a regulatory agency to a Gliadel, BCNU, NSC-409962, Becenun, Carmustine manufacturer, verifying that the manufacturing facility of a Gliadel, BCNU, NSC-409962, Becenun, Carmustine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Gliadel, BCNU, NSC-409962, Becenun, Carmustine APIs or Gliadel, BCNU, NSC-409962, Becenun, Carmustine finished pharmaceutical products to another nation, regulatory agencies frequently require a Gliadel, BCNU, NSC-409962, Becenun, Carmustine WC (written confirmation) as part of the regulatory process.
click here to find a list of Gliadel, BCNU, NSC-409962, Becenun, Carmustine suppliers with Written Confirmation (WC) on PharmaCompass.